Clarithromycin 500mg

DRUG18 trials

Sponsors

Ranbaxy Laboratories Limited, HK inno.N Corporation, Il-Yang Pharm. Co., Ltd., Inje University, Universidade Estadual Paulista Júlio de Mesquita Filho

Conditions

Aggressive Periodontitis, GeneralizedAntibiotic Resistant InfectionAntibiotic Resistant StrainBiomarkersCommunity-acquired PneumoniaCovid19Drug Interaction PotentiationDyspepsia

Early Phase 1

Assessment and Management of Chronic Dyspepsia in Eastern Uganda

CompletedNCT04525664

Washington University School of MedicineDyspepsia, Helicobacter Pylori Infection

Start: 2018-10-01End: 2020-06-30Updated: 2020-08-25

Phase 1

Drug-Drug Interaction Study Between CJ-12420 and Clarithromycin in Healthy Male Subjects

CompletedNCT02052336

HK inno.N CorporationHealthy

Start: 2013-10-31End: 2014-11-30Updated: 2016-12-15

Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Clarithromycin, Amoxicillin and Ilaprazole

CompletedNCT02998437

Il-Yang Pharm. Co., Ltd.Drug Interaction Potentiation

Start: 2016-12-31End: 2017-01-31Updated: 2017-01-26

Evaluate the Effect of Clarithromycin/Rifampicin on the Pharmacokinetics of DA-8010 in Healthy Adults

CompletedNCT05991401

Dong-A ST Co., Ltd.Healthy

Start: 2023-08-18End: 2023-11-17Updated: 2024-01-25

Phase 2

Periodontal Debridement Associated With Systemic Antibiotics and Single/Repeated PDT to Treat Aggressive Periodontitis

CompletedNCT03132714

Universidade Estadual Paulista Júlio de Mesquita FilhoAggressive Periodontitis, Generalized

Start: 2015-03-31End: 2016-10-31Updated: 2017-04-28

Phase 3

Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection.

University of BariAntibiotic Resistant Infection, Antibiotic Resistant Strain, Helicobacter Pylori Infection

Start: 2020-01-14End: 2022-04-14Target: 362Updated: 2021-01-12

Anti-inflammatory Action of Oral Clarithromycin in Community-acquired Pneumonia

CompletedNCT04724044

Hellenic Institute for the Study of SepsisBiomarkers, Community-acquired Pneumonia, Inflammatory Response +3

Start: 2021-01-25End: 2023-04-11Updated: 2023-12-12

Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT)

RecruitingNCT06294600

Hellenic Institute for the Study of SepsisCommunity-acquired Pneumonia

Start: 2024-02-12End: 2026-07-30Target: 330Updated: 2025-12-16

Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori

CompletedNCT06751121

Daewoong Pharmaceutical Co. LTD.Helicobacter Pylori Infected Patients, Helicobacter Pylori Infected Subjects, Helicobacter Pylori Infection

Start: 2024-02-06End: 2025-04-24Updated: 2025-12-08

Phase 4

Helicobacter Pylori Eradication Study

CompletedNCT03130452

Inje UniversityHelicobacter Pylori Infection

Start: 2016-12-17End: 2019-05-31Updated: 2025-05-01

10 vs 14 Days Triple Therapy : H.Pylori Infection Eradication

Indonesia UniversityHelicobacter Pylori Infection

Start: 2016-10-03End: 2017-05-12Target: 73Updated: 2017-04-28

Genotypic Resistance-guided Versus Empirical Therapy for H. Pylori Eradication.

Konstantopoulio-Patission General Hospital of Nea IoniaHelicobacter Pylori Infection

Start: 2019-09-01End: 2020-02-28Target: 304Updated: 2019-09-19

The Epidemiology and Optimal Treatment of Helicobacter Pylori in Myanmar

CompletedNCT04132479

Kirby InstituteHelicobacter Pylori Infection

Start: 2018-01-01End: 2019-04-09Updated: 2019-10-18

Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)

RecruitingNCT06396078

Ohio State UniversityPregnancy, High Risk, Preterm Birth, Preterm Premature Rupture of Membrane

Start: 2024-07-18End: 2026-12-01Target: 56Updated: 2026-01-27

Unknown Phase

Bioequivalence Study of Clarithromycin 500mg Tablets Under Fasting Conditions.

CompletedNCT00774644

Ranbaxy Laboratories LimitedHealthy

Start: 2002-12-31End: 2003-02-28Updated: 2008-11-18

Dexlansoprazole MR-Based Concomitant Quadruple Therapy

CompletedNCT03829150

Chang Gung Memorial HospitalHelicobacter Pylori Infection

Start: 2017-03-01End: 2019-04-20Updated: 2019-05-14

Clarithromycin Versus Azithromycin in Treatment of Mild COVID-19 Infection

CompletedNCT04622891

South Valley UniversityCovid19

Start: 2020-04-01End: 2020-07-30Updated: 2020-11-10

Helicobacter Pylori Eradication in Functional Dyspepsia

CompletedNCT04697641

Sir Ganga Ram HospitalDyspepsia, Helicobacter Pylori Infection

Start: 2017-09-01End: 2019-05-31Updated: 2021-01-14

Related Papers

Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial.

2024-01-0337 citations

Evaluation of pharmacokinetic drug-drug interaction between tegoprazan and clarithromycin in healthy subjects

Translational and Clinical Pharmacology2023-01-019 citations

Role of Helicobacter pylori eradication in patients with functional dyspepsia.

2021-10-276 citations

Therapeutic efficacy of macrolides in management of patients with mild COVID-19.

2021-08-1120 citations

<p>A comparison between dexlansoprazole modified release–based and lansoprazole-based nonbismuth quadruple (concomitant) therapy for first-line <em>Helicobacter pylori</em> eradication: a prospective randomized trial</p>

Infection and Drug Resistance2019-09-0110 citations

Pharmacokinetic drug interaction and safety after coadministration of clarithromycin, amoxicillin, and ilaprazole: a randomised, open-label, one-way crossover, two parallel sequences study

European Journal of Clinical Pharmacology2018-05-3011 citations